GLP-1 & Semaglutide Blog (India)
Expert-written articles on GLP-1 therapy in India — eligibility, pricing, side-effect management, brand selection, and patient pathways. Reviewed against published Indian and international clinical evidence (RSSDI 2024 guidelines, ESI obesity guidelines, INASL fatty-liver guidelines, plus STEP, SUSTAIN, SURMOUNT, and SELECT trial data).
Compiled by the GLP-1 Check Editorial team · Updated regularly
Also on GLP-1 Check
7 articles — most recent first
What to Eat on Semaglutide: An Indian Diet Guide
What to actually eat on Ozempic, Wegovy, or generic semaglutide in India: protein-first plates, smaller rotis, vegetarian protein options, and the foods that make side effects worse.
How Much Weight Will You Lose on Semaglutide? A Realistic Timeline
How much weight you can realistically lose on semaglutide (Ozempic/Wegovy), and when — a month-by-month timeline grounded in the STEP trials, plus what makes results better or worse.
The Generic Semaglutide Era in India (2026): What Cheaper Ozempic Really Means
In March 2026 India's semaglutide patent expired and prices crashed. Here's what really changed for patients: the current prices, the pen-vs-vial pricing trap, and how to choose safely.
Injecting and Storing Semaglutide in Indian Heat: A Practical Cold-Chain Guide
How to store and inject semaglutide (Ozempic, Wegovy, generics) safely in Indian conditions: fridge temperatures, power cuts, travel, injection technique, and missed doses.
Your BMI Is 24. Your Doctor Says You're Fine. Indian Guidelines Tell a Different Story.
Most online BMI calculators use Western thresholds. For Indians, those numbers are clinically wrong. Here is what Indian guidelines actually say — and what it means for whether you qualify for semaglutide.
Semaglutide Side Effects: What Indian Patients Actually Experience
Most people researching semaglutide find side effect lists written for Western patients. Here is what Indian clinical data and real-world experience actually shows — and what you can do about it.
Am I Eligible for Semaglutide in India? The Complete Clinical Checklist (2026)
With generic semaglutide now available from ₹1,290/month, millions of Indians are asking: do I qualify? This clinical checklist — built on Indian BMI thresholds, not Western guidelines — tells you exactly what to assess before speaking to your doctor.
What we cover
Eligibility & Indian guidelines
BMI thresholds, comorbidity criteria, RSSDI / ESI guideline interpretation, when GLP-1 is on-label vs off-label in India.
Pricing & affordability
Brand-by-brand India pricing, innovator vs generic value, post-patent-expiry pricing dynamics, hidden costs.
Side effects & management
GI side effects during titration, diet adjustment for Indian patients, rare but important events, when to seek help.
Conditions & populations
GLP-1 for PCOS, type 2 diabetes, prediabetes, NAFLD/MASH, hypertension, sleep apnea — Indian-specific considerations.
See if GLP-1 fits your profile
5-minute Indian-guideline eligibility check. BMI, comorbidities, lab values (optional) — evidence-based starting point.
Take the free assessment →